(NEW YORK)Shares of biotechnology company Biogen Idec Inc. jumped Tuesday after its partner on the blockbuster drug Rituxan reported a surge in second-quarter sales.READ MORE
(FRAZER, Pa.)Biotechnology company Cephalon Inc. said Tuesday its leukemia drug Treanda, in combination with Genentech Inc.'s Rituxan, prompted a response in non-Hodgkin's lymphoma patients dur...READ MORE
(NEW YORK)Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesd...READ MORE
(NEW YORK)The Nasdaq 100 index dropped sharply Friday with high oil prices weighing on shares of UAL Corp., which operates United Airlines. UAL declined 95 cents, or 11.7 percent, to $7.16. ...READ MORE
(NEW YORK)Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts sai...READ MORE
(WASHINGTON)Government regulators said Thursday they are preparing to allow highly addictive medications, including powerful painkillers, to be prescribed online, a goal long-sought by health ...READ MORE
(NEW YORK)The Nasdaq 100 sank Friday after the Labor Department said unemployment jumped last month to levels not seen in 22 years, and crude oil soared to a new record just under $140 a bar...READ MORE